全身麻酔薬の世界市場:産業分析・機会分析

◆英語タイトル:General Anaesthesia Drugs Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025
◆商品コード:FMI609072
◆発行会社(調査会社):Future Market Insights
◆発行日:2015年9月4日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。



※本調査レポートでは、全身麻酔薬の世界市場について調査・分析し、市場概観、全身麻酔薬の世界市場規模、市場規模予測、地域別分析(アメリカ、ヨーロッパ、アジア等)、セグメント別市場分析、競争状況、全身麻酔薬市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Future Market Insights offers a 10-year forecast of the global general anaesthesia drugs market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 3.8% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the general anaesthesia drugs market over the forecast period.
Report Description

This Future Market Insights report examines the general anaesthesia drugs market for the period of 2015–2025. The primary objective of the report is to offer insights into developments in the general anaesthesia drugs market that are significantly transforming global businesses and enterprises. Increasing incidences of cardiovascular and chronic diseases, coupled with rising demand for surgical procedures is predicted to increase usages of general anaesthesia drugs worldwide. This is expected to bolster growth of the general anaesthesia drugs market over the next five to six years. Increasing demand for inhalation general anaesthesia drugs, for maintaining the sedative stage during surgical procedures, especially among the children and elderly population is expected to drive growth of general anaesthesia drugs market during the forecast period. Companies are focused on populations driving the market such as: Asia Pacific and MEA, where incidences of cardiovascular and chronic disease are increasing, this is expected to further increase the demand of general anaesthesia drugs during surgical procedures.

The general anaesthesia drugs market report begins with an overview of the general anaesthesia drugs market in terms of value. This section includes FMI’s analysis of key trends, drivers and restraints, and opportunity, all factors that are influencing the general anaesthesia drugs market. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in the general anaesthesia drugs market report to better equip clients with crystal clear decision-making insights.

The global general anaesthesia drugs market is segmented on the basis of products type as: Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam and Others.A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and BPS analysis, for general anaesthesia drugs market across the globe.

The next section of the report highlights general anaesthesia drugs adoption by region. It provides a market outlook for 2015–2025 and sets the forecast within the context of the general anaesthesia drugs market. The study discusses the key regional trends contributing to growth of the general anaesthesia drugs market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa.

All the above sections, by product type and region, evaluate the present scenario and growth prospects of the general anaesthesia drugs market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the following 12 months.

To calculate general anaesthesia drugs market size, we have also considered revenue generated by the manufacturers. The forecast presented here assesses the total revenue by value across the general anaesthesia drugs market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the general anaesthesia drugs market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the general anaesthesia drugs market.

As previously highlighted, the general anaesthesia drugs market is split into a number of segments. All the general anaesthesia drugs segments in terms of product and regions are analysed in terms of Basis Point Share to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the general anaesthesia drugs market.

Another key feature of this report is the analysis of all key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the general anaesthesia drugs market.

To understand key growth segments in terms of growth and adoption for —cardiovascular disease (CVD) and chronic disease— surgical procedures across the globe in the near future, Future Market Insights developed the general anaesthesia drugs market ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.

In the final section of the report, general anaesthesia drugs a ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the value chain of the general anaesthesia drugs product portfolio and key differentiators. Key categories of providers covered in the report are general anaesthesia drug manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the general anaesthesia drugs value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in general anaesthesia drugs marketplace.

Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the general anaesthesia drugs market. Key competitors covered in terms of manufacturers are: Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA and Hospira Inc.

Key Segments Covered

Product Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
Others

Key Regions/Countries Covered

North America
US
Canada
Latin America
Brazil
Argentina
Mexico
Western Europe
EU5
Nordics
BENELUX
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Greater China
India
ASEAN
Australia and New Zealand
Rest of APEJ
Japan
Middle East & Africa
GCC
South Africa
Israel
Turkey
Rest of MEA

Key Companies

Baxter International Inc.
AstraZeneca
AbbVie Inc.
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
Hospira Inc.

【レポートの目次】

Table Of Content
1. Assumptions & Acronyms Used
2. Research Methodology
3. Executive Summary
4. Global General Anaesthesia Drugs Market
4.1. Taxonomy
4.2. Introduction
5. Global General Anaesthesia Drugs Market Overview
5.1. Global General Anaesthesia Drugs Market Analysis
5.1.1. Global General Anaesthesia Drugs Market Value Forecast, 2013–2025
5.1.2. Global General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2025
5.1.3. Global General Anaesthesia Drugs Market Y-o-Y Growth Forecast, 2014–2025
5.2. Global General Anaesthesia Drugs Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
6. Global General Anaesthesia Drugs Market Outlook, By Product
6.1. Introduction
6.2. Market Value Share & BPS Analysis
6.3. Propofol
6.3.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.3.2. Market Value Absolute $ Opportunity, 2014–2020
6.4. Sevoflurane
6.4.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.4.2. Market Value Absolute $ Opportunity, 2014–2020
6.5. Dexmedetomidine
6.5.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.5.2. Market Value Absolute $ Opportunity, 2014–2020
6.6. Desflurane
6.6.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.6.2. Market Value Absolute $ Opportunity, 2014–2020
6.7. Remifentanil
6.7.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.7.2. Market Value Absolute $ Opportunity, 2014–2020
6.8. Midazolam
6.8.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.8.2. Market Value Absolute $ Opportunity, 2014–2020
6.9. Others
6.9.1. Market Value & Y-o-Y Growth Forecast, 2014–2025
6.9.2. Market Value Absolute $ Opportunity, 2014–2020
7. Global General Anaesthesia Drugs Market Outlook, By Region
8. Global General Anaesthesia Drugs Market, By Region
8.1. Introduction
8.2. Market Value Share and BPS Analysis, By Region
8.3. North America General Anaesthesia Drugs Market Analysis and Forecast
8.3.1. North America General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.3.2. North America General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2025
8.3.3. North America General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.3.4. North America General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product, 2015–2025
8.3.5. North America General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.3.5.1. U.S. General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.3.5.2. Canada General Anaesthesia Drugs Market Analysis and Forecast By Product
8.4. Latin America General Anaesthesia Drugs Market Analysis and Forecast
8.4.1. Latin America General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.4.2. Latin America General Anaesthesia Drugs Market Absolute $ Opportunity
8.4.3. Latin America General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.4.4. Latin America General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product
8.4.5. Latin America General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.4.5.1. Argentina General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.4.5.2. Brazil General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.4.5.3. Mexico General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.4.5.4. Rest of Latin America General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5. Western Europe General Anaesthesia Drugs Market Analysis and Forecast
8.5.1. Western Europe General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.5.2. Western Europe General Anaesthesia Drugs Market Absolute $ Opportunity
8.5.3. Western Europe General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.5.4. Western Europe General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product
8.5.5. Western Europe General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.1. Germany General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.2. U.K. General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.3. France General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.4. Italy General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.5. Spain General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.6. NORDIC General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.7. BENELUX General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.5.5.8. Rest of Western Europe General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.6. Eastern Europe General Anaesthesia Drugs Market Analysis and Forecast
8.6.1. Eastern Europe General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.6.2. Eastern Europe General Anaesthesia Drugs Market Absolute $ Opportunity
8.6.3. Eastern Europe General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.6.4. Eastern Europe General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product
8.6.5. Eastern Europe General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.6.5.1. Poland General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.6.5.2. Russia General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.6.5.3. Rest of Western Europe General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.7. APEJ General Anaesthesia Drugs Market Analysis and Forecast
8.7.1. APEJ General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.7.2. APEJ General Anaesthesia Drugs Market Absolute $ Opportunity
8.7.3. APEJ General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.7.4. APEJ General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product
8.7.5. APEJ General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.7.5.1. Greater China General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.7.5.2. India General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.7.5.3. ASEAN General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.7.5.4. Australia & New Zealand General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.7.5.5. Rest of APEJ General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.8. Japan General Anaesthesia Drugs Market Analysis and Forecast
8.8.1. Japan General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.8.2. Japan General Anaesthesia Drugs Market Absolute $ Opportunity
8.8.3. Japan General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.8.4. Japan General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product
8.8.5. Japan General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.9. MEA General Anaesthesia Drugs Market Analysis and Forecast
8.9.1. MEA General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast
8.9.2. MEA General Anaesthesia Drugs Market Absolute $ Opportunity
8.9.3. MEA General Anaesthesia Drugs Market Value Share & BPS Analysis, By Product
8.9.4. MEA General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product
8.9.5. MEA General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.9.5.1. GCC General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.9.5.2. South Africa General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.9.5.3. Israel General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.9.5.4. Turkey General Anaesthesia Drugs Market Analysis and Forecast, By Product
8.9.5.5. Rest of MEA General Anaesthesia Drugs Market Analysis and Forecast, By Product
9. Competitive Landscape
9.1. Competitive Dashboard
9.2. Company Profiles
9.2.1. Baxter International Inc.
9.2.1.1. Overview
9.2.1.2. Key Financials
9.2.2. AstraZeneca
9.2.2.1. Overview
9.2.2.2. Key Financials
9.2.3. AbbVie Inc.
9.2.3.1. Overview
9.2.3.2. Key Financials
9.2.4. B. Braun Melsungen AG
9.2.4.1. Overview
9.2.4.2. Key Financials
9.2.5. Fresenius SE & Co. KGaA
9.2.5.1. Overview
9.2.5.2. Key Financials
9.2.6. Hospira Inc.
9.2.6.1. Overview
9.2.6.2. Key Financials



【レポートのキーワード】

全身麻酔薬

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[全身麻酔薬の世界市場:産業分析・機会分析]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月05日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆